TG Therapeutics, Inc. (TGTX)
NASDAQ · Healthcare
TG Therapeutics, Inc. Operating Income 2020–2025
TG Therapeutics, Inc. annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- TG Therapeutics, Inc. operating income for the quarter ending March 31, 2026 was 34.8 M, a 303.56% increase year-over-year.
- TG Therapeutics, Inc. operating income for the twelve months ending March 31, 2026 was 149.5 M.
- TG Therapeutics, Inc. annual operating income for 2025 was 123.3 M, a 194.13% increase from 2024.
- TG Therapeutics, Inc. annual operating income for 2024 was 41.9 M, a 103.21% increase from 2023.
- TG Therapeutics, Inc. annual operating income for 2023 was 20.6 M, a 110.70% decrease from 2022.
- TG Therapeutics, Inc. annual operating income for 2022 was -192.8 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
TG Therapeutics, Inc. Operating Income — FAQ
TG Therapeutics, Inc. (TGTX) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is TG Therapeutics, Inc.'s operating income?
TG Therapeutics, Inc. (TGTX) reported operating income of $123M for fiscal 2025.
Where can I see TGTX's operating income history?
The chart and table above show TG Therapeutics, Inc.'s operating income by year and by quarter, including the growth rate.